Inhibikase Therapeutics Share Price (NASDAQ: IKT)
$1.75
Live
Last updated on
Check the interactive Inhibikase Therapeutics Stock chart to analyse performance
Inhibikase Therapeutics stock performance
as on August 18, 2025 at 11:47 PM IST
- Today's Low:$1.75Today's High:$1.75
0.0%
Downside
Day's Volatility :0.0%
Upside
0.0%
- 52 Weeks Low:$1.1252 Weeks High:$4.20
36.0%
Downside
52 Weeks Volatility :73.33%
Upside
58.33%
Inhibikase Therapeutics Stock Returns
Inhibikase Therapeutics Inc Key Stats
Check Inhibikase Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Inhibikase Therapeutics Stock including INR - Dollar returns
The Inhibikase Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inhibikase Therapeutics investment value today
Current value as on today
₹1,40,792
Returns
₹40,792
(+40.79%)
Returns from Inhibikase Therapeutics Stock
₹36,719 (+36.72%)
Dollar Returns*
₹4,073 (+4.07%)
Indian investors sentiment towards Inhibikase Therapeutics Stock
Global Institutional Holdings in Inhibikase Therapeutics Inc
Name
Holdings %
Sands Capital Ventures, LLC
14.73%
Soleus Capital Management, L.P.
8.51%
Fairmount Funds Management LLC
8.24%
Perceptive Advisors LLC
7.31%
COMMODORE CAPITAL LP
7.19%
ADAR1 Capital Management LLC
6.89%
Analyst Recommendation on Inhibikase Therapeutics Stock
Buy
83%Buy
16%Hold
0%Sell
Based on 6 Wall street analysts offering stock ratings for Inhibikase Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Inhibikase Therapeutics Share Price Target
What analysts predicted
Upside of 357.14%
Target:
$8.00
Current:
$1.75
Inhibikase Therapeutics share price target is $8.00, a slight Upside of 357.14% compared to current price of $1.75 as per analysts' prediction.
Inhibikase Therapeutics Stock Insights
Price Movement
In the last 7 days, IKT stock has moved up by 15.9%Increasing Revenue
Revenue is up for the last 2 quarters, 1.0 → 26.27K (in $), with an average increase of 100.0% per quarterDecreasing Net Profit
Netprofit is down for the last 6 quarters, -4.17M → -13.67M (in $), with an average decrease of 31.4% per quarterIKT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 29.6%IKT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 164.5%
Inhibikase Therapeutics Technicals Summary
Sell
Neutral
Buy
Inhibikase Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Inhibikase Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -6.91% | -32.69% | 36.72% | -61.36% | -97.05% |
 | 6.39% | -14.65% | -51.51% | -6.14% | -7.82% |
 | 10.08% | 34.96% | 66.94% | 83.8% | 36.85% |
 | -14.33% | -15.0% | -19.52% | 31.35% | 45.44% |
 | 40.06% | 79.56% | 63.55% | 107.86% | 227.15% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | 0.0 | -0.97 | -0.57 | NA | 1.07 |
| 14.62 | 14.62 | 1.19 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.33 | -0.05 | -0.01 | NA | 34.32 |
| 27.94 | 27.94 | 0.58 | 18.04 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $130.1M | -97.05% | NA | 0.0% |
| Buy | $61.5B | -7.82% | 14.62 | 31.37% |
| NA | $38.8B | 36.85% | NA | -3.89% |
| Buy | $100.7B | 45.44% | 27.94 | 31.86% |
| Buy | $58.0B | 227.15% | NA | -12.96% |
About Inhibikase Therapeutics Inc
Key Management of Inhibikase Therapeutics Inc
Important FAQs about investing in IKT Stock from India :
What is Inhibikase Therapeutics share price today?
Inhibikase Therapeutics share price today is $1.75 as on . Inhibikase Therapeutics share today touched a day high of $1.75 and a low of $1.75.
What is the 52 week high and 52 week low for Inhibikase Therapeutics share?
Inhibikase Therapeutics share touched a 52 week high of $4.20 and a 52 week low of $1.12. Inhibikase Therapeutics stock price today, is trending at $1.75, lower by 58.33% versus the 52 week high.
How to invest in Inhibikase Therapeutics Stock (IKT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Inhibikase Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inhibikase Therapeutics Shares that will get you 0.8571 shares as per Inhibikase Therapeutics share price of $1.75 per share as on August 18, 2025 at 11:47 PM IST.
What is the minimum amount required to buy Inhibikase Therapeutics Stock (IKT) from India?
Indian investors can start investing in Inhibikase Therapeutics (IKT) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Inhibikase Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 18, 2025).
Based on Inhibikase Therapeutics share’s latest price of $1.75 as on August 18, 2025 at 11:47 PM IST, you will get 5.7143 shares of Inhibikase Therapeutics. Learn more about
fractional shares .
What are the returns that Inhibikase Therapeutics has given to Indian investors in the last 5 years?
Inhibikase Therapeutics stock has given -97.05% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Motorsport Games Inc.$2.98
+2.76%
Universal Technical Institute Inc$26.39
+1.38%
Dakota Gold Corp$3.99
+0.0%
Skywater Technology Inc$11.56
+1.31%
- Creative Global Technology Holdings Limited
$0.72
-6.49%
Grindrod Shipping Holdings L$26.17
+2.19%
- Aam Slc Low Duration Income Etf
$25.25
-0.08%
